Tags

Type your tag names separated by a space and hit enter

Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Eur J Clin Invest. 2006 Jun; 36(6):409-18.EJ

Abstract

BACKGROUND

Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy as the over-expressed MDR protein acts as an efflux pump, which leads to a reduction in the uptake of the anticancer agent by tumour cells. We combined topotecan and amlodipine together into the stealthy liposomes, in which amlodipine was applied as a MDR reversing agent to overcome the resistance.

MATERIALS AND METHODS

Cytotoxicity, apoptosis and the signalling pathway assays were performed on human chronic myelogenous leukaemia K562, promyelocytic leukaemia HL-60 and MDR HL-60 cells, respectively. Pharmacokinetics and antitumour activity studies were performed on normal Kunming mice and female BALB/c nude mice with MDR HL-60 xenografts, respectively.

RESULTS

Topotecan alone was effective in inhibiting the growth of non-resistant leukaemia cells, K562 and HL-60 cells but not the growth of MDR HL-60 cells. The resistance of topotecan in MDR HL-60 cells was potently reversed by the addition of amlodipine. Moreover, amlodipine enhanced the apoptosis-inducing effect of topotecan synergistically. Apoptosis was through activating caspases in a cascade: first, the initiator caspase 8 and then effectors caspase 3/7 (total activity of caspases 3 and 7) were activated. Being encapsulated into the stealthy liposomes with an acidic internal medium, topotecan existed dominantly in an active lactone species, which was reversibly changed from an inactive carboxylate form via a pH-dependent reaction. After administration of stealthy liposomes to mice, the blood exposure of the lactone form was evidently increased and extended. The antitumour effects in the MDR HL-60 xenografted tumour were stealthy liposomal topotecan (SLT) plus amlodipine > SLT > un-encapsulated topotecan > blank control.

CONCLUSIONS

The enhanced antitumour activity in the MDR HL-60 cells by the SLT plus amlodipine could be owing to multiple reasons: (a) synergistic apoptosis inducing effect, (b) reversing MDR by amlodipine and (c) increasing the availability of active lactone of topotecan by the stealthy liposomes. The apoptosis induced by amlodipine is through caspase 8 and then the 3/7 signalling pathway.

Authors+Show Affiliations

School of Pharmaceutical Sciences and State Key Laboratory of Natural and Biometic Drugs, Peking University, Beijing, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16684125

Citation

Li, X, et al. "Effect of Stealthy Liposomal Topotecan Plus Amlodipine On the Multidrug-resistant Leukaemia Cells in Vitro and Xenograft in Mice." European Journal of Clinical Investigation, vol. 36, no. 6, 2006, pp. 409-18.
Li X, Lu WL, Liang GW, et al. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice. Eur J Clin Invest. 2006;36(6):409-18.
Li, X., Lu, W. L., Liang, G. W., Ruan, G. R., Hong, H. Y., Long, C., Zhang, Y. T., Liu, Y., Wang, J. C., Zhang, X., & Zhang, Q. (2006). Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice. European Journal of Clinical Investigation, 36(6), 409-18.
Li X, et al. Effect of Stealthy Liposomal Topotecan Plus Amlodipine On the Multidrug-resistant Leukaemia Cells in Vitro and Xenograft in Mice. Eur J Clin Invest. 2006;36(6):409-18. PubMed PMID: 16684125.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice. AU - Li,X, AU - Lu,W L, AU - Liang,G W, AU - Ruan,G R, AU - Hong,H Y, AU - Long,C, AU - Zhang,Y T, AU - Liu,Y, AU - Wang,J C, AU - Zhang,X, AU - Zhang,Q, PY - 2006/5/11/pubmed PY - 2006/9/16/medline PY - 2006/5/11/entrez SP - 409 EP - 18 JF - European journal of clinical investigation JO - Eur J Clin Invest VL - 36 IS - 6 N2 - BACKGROUND: Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy as the over-expressed MDR protein acts as an efflux pump, which leads to a reduction in the uptake of the anticancer agent by tumour cells. We combined topotecan and amlodipine together into the stealthy liposomes, in which amlodipine was applied as a MDR reversing agent to overcome the resistance. MATERIALS AND METHODS: Cytotoxicity, apoptosis and the signalling pathway assays were performed on human chronic myelogenous leukaemia K562, promyelocytic leukaemia HL-60 and MDR HL-60 cells, respectively. Pharmacokinetics and antitumour activity studies were performed on normal Kunming mice and female BALB/c nude mice with MDR HL-60 xenografts, respectively. RESULTS: Topotecan alone was effective in inhibiting the growth of non-resistant leukaemia cells, K562 and HL-60 cells but not the growth of MDR HL-60 cells. The resistance of topotecan in MDR HL-60 cells was potently reversed by the addition of amlodipine. Moreover, amlodipine enhanced the apoptosis-inducing effect of topotecan synergistically. Apoptosis was through activating caspases in a cascade: first, the initiator caspase 8 and then effectors caspase 3/7 (total activity of caspases 3 and 7) were activated. Being encapsulated into the stealthy liposomes with an acidic internal medium, topotecan existed dominantly in an active lactone species, which was reversibly changed from an inactive carboxylate form via a pH-dependent reaction. After administration of stealthy liposomes to mice, the blood exposure of the lactone form was evidently increased and extended. The antitumour effects in the MDR HL-60 xenografted tumour were stealthy liposomal topotecan (SLT) plus amlodipine > SLT > un-encapsulated topotecan > blank control. CONCLUSIONS: The enhanced antitumour activity in the MDR HL-60 cells by the SLT plus amlodipine could be owing to multiple reasons: (a) synergistic apoptosis inducing effect, (b) reversing MDR by amlodipine and (c) increasing the availability of active lactone of topotecan by the stealthy liposomes. The apoptosis induced by amlodipine is through caspase 8 and then the 3/7 signalling pathway. SN - 0014-2972 UR - https://www.unboundmedicine.com/medline/citation/16684125/Effect_of_stealthy_liposomal_topotecan_plus_amlodipine_on_the_multidrug_resistant_leukaemia_cells_in_vitro_and_xenograft_in_mice_ L2 - https://doi.org/10.1111/j.1365-2362.2006.01643.x DB - PRIME DP - Unbound Medicine ER -